PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35461087-0	2022	Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1.	efavirenz	55-64	solute carrier family 2 member 1	Homo sapiens	175-181	
35461087-10	2022	Putative in silico analysis indicated the antiretrovirals, apart from efavirenz, associated with the binding site of highest binding affinity to SLC2A1, similar to that of glucose.	efavirenz	70-79	solute carrier family 2 member 1	Homo sapiens	145-151